Argus Research analyst John Staszak downgrades Tyson Foods (NYSE:TSN) from Buy to Hold.
Back-To-Back Three Japanese Approvals For AstraZeneca’s Rare Disease Treatments
The Japan regulatory authority has approved AstraZeneca Plc (NASDAQ:AZN) and Merck Co Inc’s (NYSE:MRK) Lynparza (olaparib) for the adjuvant treatment of patients with…